Walgreens Boots Alliance Stock Jumps On Better Than Expected Q1 Earnings, Sticks To Annual Profit Forecast

Comments
Loading...
Zinger Key Points

On Friday, Walgreens Boots Alliance Inc (NASDAQ: WBA) reported first-quarter sales of $39.46 billion, up 7.5% year over year (+6.9% on constant currency), beating the consensus of $37.28 billion, reflecting sales growth across all segments.

Adjusted operating income was $593 million compared to adjusted operating income of $687 million in the year-ago quarter, reflecting lower U.S. retail sales and lapping prior year sale-leaseback gains, partly offset by cost savings initiatives and growth in the U.S. Healthcare segment.

Adjusted EPS was $0.51, down from $0.66 a year ago, beating the consensus of $0.37, according to data from Benzinga Pro.

Also Read: Walgreens Faces Strategic Challenges, Analysts Are Cautiously Optimistic

The U.S. Retail Pharmacy segment sales reached $30.9 billion, up 6.6%. Comparable sales increased 8.5%.

Pharmacy sales increased by 10.4%, and comparable pharmacy sales increased by 12.7%, driven by higher branded drug inflation and prescription volume.

Comparable prescriptions increased by 2.3%, and prescriptions excluding immunizations increased by 3.5% compared to a year ago.

Total prescriptions filled in the quarter, including immunizations, increased 1.5% to 316.3 million.

Retail sales decreased 6.2%, and comparable retail sales decreased 4.6% compared with the year-ago quarter, mirroring a weaker cough cold flu season and lower sales in discretionary categories.

The U.S. Healthcare segment's sales were $2.2 billion. VillageMD sales increased 9%, CareCentrix sales increased 16%, and Shields sales rose 30%.

Guidance: Walgreens Boots Alliance maintains fiscal 2025 adjusted EPS guidance of $1.40 – $1.80 versus the consensus of $1.52.

The company expects growth in U.S. Healthcare and International offset by pressure in U.S. Retail Pharmacy largely driven by weaker retail front end performance.

Price Action: WBA stock is up 16.3% at $10.72 during the premarket session at last check Friday.

Read Next:

Image via Shutterstock.

WBA Logo
WBAWalgreens Boots Alliance Inc
$10.85-0.55%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
44.52
Growth
31.65
Quality
-
Value
36.08
Price Trend
Short
Medium
Long
Got Questions? Ask
Which pharmaceutical companies may benefit from increased prescriptions?
How will Walgreens perform against competitors?
Which healthcare technology firms could thrive with Walgreens' growth?
Are retail pharmacy stocks undervalued after Walgreens' report?
Which healthcare segment shows the most potential for growth?
How might retail trends affect Walgreens' stock in the long term?
What impact will branded drug inflation have on competitors?
Could investors find value in Walgreens' international segments?
Which healthcare ETFs could benefit from Walgreens' outlook?
How does Walgreens' EPS guidance align with market expectations?
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: